Skip to main content

Development of novel targeted therapies in the treatment of malignant glioma.

Publication ,  Journal Article
Rich, JN; Bigner, DD
Published in: Nat Rev Drug Discov
May 2004

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nat Rev Drug Discov

DOI

ISSN

1474-1776

Publication Date

May 2004

Volume

3

Issue

5

Start / End Page

430 / 446

Location

England

Related Subject Headings

  • Tumor Suppressor Protein p53
  • Receptors, Vascular Endothelial Growth Factor
  • Pharmacology & Pharmacy
  • Molecular Biology
  • Middle Aged
  • Humans
  • Glioma
  • Epidermal Growth Factor
  • Clinical Trials as Topic
  • Cell Cycle
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rich, J. N., & Bigner, D. D. (2004). Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov, 3(5), 430–446. https://doi.org/10.1038/nrd1380
Rich, Jeremy N., and Darell D. Bigner. “Development of novel targeted therapies in the treatment of malignant glioma.Nat Rev Drug Discov 3, no. 5 (May 2004): 430–46. https://doi.org/10.1038/nrd1380.
Rich JN, Bigner DD. Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov. 2004 May;3(5):430–46.
Rich, Jeremy N., and Darell D. Bigner. “Development of novel targeted therapies in the treatment of malignant glioma.Nat Rev Drug Discov, vol. 3, no. 5, May 2004, pp. 430–46. Pubmed, doi:10.1038/nrd1380.
Rich JN, Bigner DD. Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov. 2004 May;3(5):430–446.

Published In

Nat Rev Drug Discov

DOI

ISSN

1474-1776

Publication Date

May 2004

Volume

3

Issue

5

Start / End Page

430 / 446

Location

England

Related Subject Headings

  • Tumor Suppressor Protein p53
  • Receptors, Vascular Endothelial Growth Factor
  • Pharmacology & Pharmacy
  • Molecular Biology
  • Middle Aged
  • Humans
  • Glioma
  • Epidermal Growth Factor
  • Clinical Trials as Topic
  • Cell Cycle